Article
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Blood - 22 Apr 2021
Belizaire Roger, Koochaki Sebastian H J, Udeshi Namrata D, Vedder Alexis, Sun Lei, Svinkina Tanya, Hartigan Christina, McConkey Marie, Kovalcik Veronica, Bizuayehu Amanuel, Stanclift Caroline, Schenone Monica, Carr Steven A, Padron Eric, Ebert Benjamin L
Abstract excerpt
Casitas B-lineage lymphoma (CBL) encodes an E3 ubiquitin ligase and signaling adaptor that regulates receptor and nonreceptor tyrosine kinases. Recurrent CBL mutations occur in myeloid neoplasms, including 10% to 20% of chronic myelomonocytic leukemia (CMML) cases, and selectively disrupt the protein's E3 ubiquitin ligase activity. CBL mutations have been associated with poor prognosis, but the oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
